RTI Health Solutions

Health technology assessment - Joint clinical assessments of medicinal products | European Commission ec.europa.eu/info/law/bette… #hta #healthtechnologyassessment #healthtech #EMA

We're excited to announce that we have joined our RTI Health Solutions colleagues under the RTI Health Solutions brand. Offering our clients a complete perspective from all healthcare stakeholders, our unity reflects RTI’s unwavering commitment to improving the human condition.

If you are attending #ICPE23, visit us at booth #1000, chat with our researchers, and scan your badge to be entered to win one of three copies of Modern Epidemiology: 4th Edition, coauthored by RTI Health Solutions expert Kenneth Rothman. ow.ly/ewwr50PmA2K

Did you know ISPOR has year-round educational learning opportunities? From our conferences to webinars, summits, short courses, roundtables, and more, there is a learning format for everyone. View our upcoming events and ramp up your #HEOR knowledge! ow.ly/GQA550PrTh2

We're attending! And here's what we'll be bringing - rtihs.org/updates-and-ev…

Medtech companies - looking for budget-friendly value assessment & evidence gap analysis? RTI-HS is a certified NICE META tool™ facilitator. Let's see if this tool is right for your product. ow.ly/h8uw50C4ak8 #digitalhealth

Looking for a team with proven performance, adherence to ISPOR and WHO best practices, and a wide range of experience to assist you with #infectiousdisease modeling? Take a look at our qualifications. ow.ly/kea150BGson

See research on how ICER'S evidence ratings are determined. ow.ly/6NBV50LAXHW #healthcare #research #costeffectiveness

RTI is proud to have earned the 2023 Military Friendly® Employer designation. ow.ly/518950MZtG2 #diversity #inclusion

Cigna has selected RTI for their 2023 silver level Healthy Workforce Designation for demonstrating a strong commitment to improving the health and well-being of its employees. ow.ly/af4F50N1bCT #EPIjobs

-How HRQOL data analysis pooled across multiple trials demonstrated extended time to deterioration in quality of life for oncology product. Read the case study->ow.ly/baQe50N9Ogi #biostatistics

Challenged with developing pre-approval information exchange (PIE) materials? We can help you communicate key pre-approval information about your medtech or #drugdevelopment. ow.ly/RA1O50NfHAj #GVD

We can help you identify potential gaps in your evidence and create a plan to address them—saving you time and costly re-work down the road. ow.ly/8Oe950Jc2G3 #pharma #CRO #drugresearch

Have you seen our case study on determining the long-term benefits of a therapy slowing kidney function decline without long-term clinical trials? Read it here->ow.ly/Rnfs50N0WVr #kidneyresearch #kidneyfunction

Our experts will be participating in two forums at #DIA2023: Post-Market Pregnancy Requirements, and Assessing Safety in Rare Disease and #GeneTherapy. Learn more ow.ly/T9Z250OzCvT @DrugInfoAssn #RWD #RWE #pharma

Our approach to providing analysis results in a consistent format across trials allows clients to easily incorporate results in reports, submissions, and publications. ow.ly/GMz150MCfTh #HTA #pharmaceutical

Our experts will be participating in two forums at #DIA2023: Post-Market Pregnancy Requirements, and Assessing Safety in #RareDisease and Gene Therapy. Learn more ow.ly/T9Z250OzCvT @DrugInfoAssn #biotech @pregnancyresearch

Research we've coauthored, Preferences for oral antipsychotic treatments: survey of patients living with bipolar I disorder, will be presented at #ISBD2023. ow.ly/LrPb50OI0aA @ISBD4

Research we've coauthored, Preferences for oral #antipsychotic treatments: survey of patients living with bipolar I disorder, will be presented at #ISBD2023. ow.ly/LrPb50OI0aA @ISBD4 #BipolarResearch

🏳‍🌈 This month, RTI is honoring #Pride2023 by celebrating our Pride Employee Resource Group (ERG). Join us as we listen to our members sharing their experiences at RTI & discussing their motivations for joining. Part 2 we spoke with Public Health Analyst, Maggie Rothenberg👇